Living with depression can be challenging, especially when symptoms continue despite trying prescribed antidepressant medications. For some adults, finding an effective treatment involves exploring options beyond traditional oral medications. One option that may be considered by an eligible patient is SPRAVATO® (esketamine) nasal spray.
At QuCiL Health™, we believe that understanding your treatment options is an important step toward making informed decisions about your mental health. If you are researching SPRAVATO® treatment in Katy, Texas, this guide explains what the treatment is, who may qualify, what to expect, and which questions to discuss with your healthcare provider.
What Is SPRAVATO®?
SPRAVATO® is a prescription nasal spray containing esketamine. It is approved for certain adults with depression, including treatment-resistant depression. Treatment-resistant depression generally refers to depression that has not responded adequately to at least two antidepressant treatments of adequate dose and duration during the current depressive episode.
SPRAVATO® works differently from many conventional antidepressants. It acts on the brain's glutamate system, including NMDA receptors, rather than primarily targeting serotonin, norepinephrine, or dopamine reuptake.
SPRAVATO® is not appropriate for everyone, and a qualified healthcare provider must assess whether it is suitable based on a patient's diagnosis, medical history, current medications, and treatment goals.
Who May Be Eligible for SPRAVATO® Treatment?
SPRAVATO® may be an option for certain adults diagnosed with treatment-resistant depression. It is also approved for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior, under specific treatment conditions. It has not been established to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically warranted.
Eligibility depends on the approved indication, the patient's health history, and an individualized clinical assessment. A provider may review previous antidepressant trials, current symptoms, other health conditions, and medications before recommending treatment.
If you have been experiencing persistent depressive symptoms despite treatment, speaking with a qualified mental health professional can help you understand which options may be appropriate for your situation.
How Does SPRAVATO® Work?
Esketamine affects the glutamate system, which is involved in communication between nerve cells in the brain. Its mechanism differs from that of many commonly prescribed oral antidepressants.
Some patients may notice improvement relatively early in treatment, but individual responses vary. SPRAVATO® is not a guaranteed solution, and improvement may take time and ongoing clinical evaluation.
Your healthcare provider will monitor your progress and determine whether the benefits of continuing treatment outweigh the potential risks.
What Happens During a SPRAVATO® Treatment Session?
SPRAVATO® must be administered under the supervision of a healthcare provider in a certified healthcare setting through the required safety program. Patients do not take the nasal spray home for unsupervised use.
A typical treatment visit may involve the following steps:
- Pre-treatment assessment: Your provider reviews your health status, medications, blood pressure, and any relevant safety concerns.
- Supervised administration: You self-administer the nasal spray under the supervision of a healthcare professional, following the prescribed instructions.
- Post-treatment monitoring: You remain at the healthcare setting for observation for at least two hours, or longer if clinically necessary.
- Discharge assessment: Your care team determines whether you are ready to leave and reviews any instructions for the remainder of the day.
Because SPRAVATO® can affect alertness, coordination, and judgment, patients must arrange transportation home and should not drive or operate machinery until the next day after a restful night's sleep. Follow the specific instructions provided by your treatment team.
How Often Is SPRAVATO® Administered?
The treatment schedule depends on the approved indication, the stage of treatment, and the prescribing clinician's assessment.
For treatment-resistant depression, treatment commonly begins with sessions twice weekly during the first four weeks. The schedule may then change to weekly sessions during the next four weeks and weekly or every-other-week sessions during maintenance, depending on clinical response and individual needs.
Your provider will determine the appropriate schedule and review whether ongoing treatment is helping. Never change your treatment schedule without consulting your healthcare professional.
What Are the Potential Side Effects?
SPRAVATO® can cause side effects, and patients should understand the risks before starting treatment. Common side effects may include:
- Dissociation or feeling disconnected from yourself or your surroundings
- Dizziness or a spinning sensation
- Nausea or vomiting
- Sleepiness or sedation
- Increased blood pressure
- Reduced sensation or a feeling of numbness
- Anxiety or feeling unusually emotional
More serious risks include respiratory depression, impaired judgment, and misuse. Because of these risks, SPRAVATO® is subject to a restricted safety program in the United States. Healthcare professionals monitor patients after administration for sedation, dissociation, breathing problems, and changes in blood pressure.
Tell your provider about your complete medical history, including uncontrolled high blood pressure, vascular conditions, a history of substance use disorders, pregnancy, and all prescription or nonprescription medications you take. Certain conditions may make SPRAVATO® unsuitable.
Seek immediate medical attention if you experience severe breathing difficulties, chest pain, or another serious or unexpected reaction.
Is SPRAVATO® the Same as Traditional Ketamine Treatment?
No. Although esketamine is related to ketamine, SPRAVATO® is a specifically approved prescription nasal spray with defined indications, dosing requirements, monitoring procedures, and safety restrictions.
Other ketamine treatments may use different formulations, routes of administration, and clinical protocols. Their regulatory status and evidence may differ. Ask your healthcare provider to explain the differences and the evidence supporting any treatment being considered.
Does SPRAVATO® Replace Antidepressant Medication or Therapy?
For treatment-resistant depression, SPRAVATO® is approved for use alongside an oral antidepressant. For depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior, its approved use has different conditions, and an oral antidepressant is not required by the indication itself.
Your provider will explain which treatment plan applies to you. Psychotherapy, medication management, lifestyle support, and regular follow-up may also play a role in a broader mental health care plan.
Do not stop or change any prescribed medication without first discussing it with your healthcare provider.
How Can You Explore SPRAVATO® Treatment in Katy, TX?
If you are looking into SPRAVATO® treatment or other depression treatment options in Katy, Texas, start by arranging an assessment with a qualified healthcare provider. A clinical evaluation can help clarify your diagnosis, review previous treatments, identify safety considerations, and determine whether a referral or specialized treatment program is appropriate.
QuCiL Health™ provides healthcare services for adults and encourages patients to discuss their mental health concerns openly with a qualified provider. Contact the practice to ask about available mental health services, whether SPRAVATO® assessment or treatment is offered, and what the next steps may involve.
QuCiL Health™
3107 Elrod Rd, Suite G
Katy, TX 77494
When contacting a healthcare practice, consider asking:
- Do you offer SPRAVATO® evaluations or supervised treatment at this location?
- What clinical criteria determine eligibility?
- What monitoring and follow-up are required?
- Does my insurance plan cover the treatment, and what out-of-pocket costs may apply?
- What transportation arrangements will I need after each session?
Service availability, eligibility, and insurance coverage should be confirmed directly with the practice and your insurance provider.
Frequently Asked Questions About SPRAVATO®
How quickly does SPRAVATO® work?
Some patients experience improvement early in treatment, while others need more time or may not respond. Your provider will assess changes in symptoms throughout treatment rather than relying on a single session.
Is SPRAVATO® suitable for everyone with depression?
No. It is approved for specific conditions and requires a clinical evaluation. Your diagnosis, previous treatments, medical history, medications, and potential risks all influence whether it may be appropriate.
Can I drive myself home after treatment?
No. Patients should arrange transportation after each session. Do not drive or operate machinery until the next day after a restful night's sleep, as directed by the treatment team.
Does insurance cover SPRAVATO®?
Coverage varies by insurance plan, clinical indication, provider network, and authorization requirements. Contact your insurer and the treatment provider to verify benefits, prior authorization, medication costs, and administration fees.
Where can I ask about depression treatment in Katy, Texas?
You can contact QuCiL Health™ at 3107 Elrod Rd, Suite G, Katy, TX 77494, to ask about available adult healthcare and mental health services, including whether SPRAVATO® evaluation or treatment is offered.
Take an Informed Step Toward Mental Health Care
Living with persistent depression can be difficult, but you do not have to navigate treatment decisions without professional guidance. Learning about available options, understanding their potential risks and benefits, and working with a qualified healthcare provider can help you make informed choices about your care.
If you are exploring depression treatment options in Katy, TX, contact QuCiL Health™ to discuss available services and the appropriate next step for your needs.
Medical disclaimer: This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. SPRAVATO® has important risks and requires administration and monitoring under its approved safety program. Treatment decisions should be made with a qualified healthcare provider. If you are experiencing a mental health emergency or are in immediate danger, call 911 or go to the nearest emergency department.
Community Discussion 0
Privacy Notice
Please DO NOT share: Personal health information or contact details.
Comments are moderated to protect patient privacy.
Share Your Thoughts
No comments yet. Be the first to share your thoughts!